APO Research
Talk to an analyst

APO RESEARCH · REPORT

Molnupiravir

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Molnupiravir Market Analysis and Forecast 2026-2032

30 December 2025195 pages

Choose your research edition.

Industry ResearchMolnupiravir Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Molnupiravir Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Molnupiravir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Molnupiravir Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Molnupiravir Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Molnupiravir market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Molnupiravir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Molnupiravir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Molnupiravir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Molnupiravir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Molnupiravir include Merck, Sun Pharma, Optimus Pharma and Beximco, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Molnupiravir, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Molnupiravir, also provides the sales of main regions and countries. Of the upcoming market potential for Molnupiravir, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Molnupiravir sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Molnupiravir market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Molnupiravir sales, projected growth trends, production technology, application and end-user industry.

Molnupiravir Segment by Company

Merck

Sun Pharma

Optimus Pharma

Beximco

Molnupiravir Segment by Type

Patented Drug

Generic Drug

Molnupiravir Segment by Application

Antiviral Drug

COVID-19

Molnupiravir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molnupiravir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molnupiravir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molnupiravir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Molnupiravir in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Molnupiravir manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molnupiravir sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Molnupiravir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Patented Drug Major Manufacturers Table 3. Generic Drug Major Manufacturers Table 4. Global Molnupiravir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Antiviral Drug Major Manufacturers Table 6. COVID-19 Major Manufacturers Table 7. Molnupiravir Industry Trends Table 8. Molnupiravir Industry Drivers Table 9. Molnupiravir Industry Opportunities and Challenges Table 10. Molnupiravir Industry Restraints Table 11. Global Molnupiravir Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Molnupiravir Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Molnupiravir Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Molnupiravir Revenue Market Share by Region (2021-2026) Table 15. Global Molnupiravir Revenue Market Share by Region (2027-2032) Table 16. Global Molnupiravir Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Molnupiravir Sales by Region (2021-2026) & (K Units) Table 18. Global Molnupiravir Sales by Region (2027-2032) & (K Units) Table 19. Global Molnupiravir Sales Market Share by Region (2021-2026) Table 20. Global Molnupiravir Sales Market Share by Region (2027-2032) Table 21. Global Molnupiravir Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Molnupiravir Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Molnupiravir Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Molnupiravir Sales Market Share by Manufacturers (2021-2026) Table 25. Global Molnupiravir Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Molnupiravir Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Molnupiravir Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Molnupiravir Manufacturers, Product Type & Application Table 29. Global Molnupiravir Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Molnupiravir by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Molnupiravir Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Molnupiravir Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Molnupiravir Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Molnupiravir Revenue Market Share by Type (2021-2026) Table 36. Global Molnupiravir Revenue Market Share by Type (2027-2032) Table 37. Global Molnupiravir Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Molnupiravir Sales by Type (2021-2026) & (K Units) Table 39. Global Molnupiravir Sales by Type (2027-2032) & (K Units) Table 40. Global Molnupiravir Sales Market Share by Type (2021-2026) Table 41. Global Molnupiravir Sales Market Share by Type (2027-2032) Table 42. Global Molnupiravir Price by Type (2021-2026) & (US$/Unit) Table 43. Global Molnupiravir Price by Type (2027-2032) & (US$/Unit) Table 44. Global Molnupiravir Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Molnupiravir Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Molnupiravir Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Molnupiravir Revenue Market Share by Application (2021-2026) Table 48. Global Molnupiravir Revenue Market Share by Application (2027-2032) Table 49. Global Molnupiravir Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Molnupiravir Sales by Application (2021-2026) & (K Units) Table 51. Global Molnupiravir Sales by Application (2027-2032) & (K Units) Table 52. Global Molnupiravir Sales Market Share by Application (2021-2026) Table 53. Global Molnupiravir Sales Market Share by Application (2027-2032) Table 54. Global Molnupiravir Price by Application (2021-2026) & (US$/Unit) Table 55. Global Molnupiravir Price by Application (2027-2032) & (US$/Unit) Table 56. Merck Company Information Table 57. Merck Business Overview Table 58. Merck Molnupiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Merck Molnupiravir Product Portfolio Table 60. Merck Recent Development Table 61. Sun Pharma Company Information Table 62. Sun Pharma Business Overview Table 63. Sun Pharma Molnupiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Sun Pharma Molnupiravir Product Portfolio Table 65. Sun Pharma Recent Development Table 66. Optimus Pharma Company Information Table 67. Optimus Pharma Business Overview Table 68. Optimus Pharma Molnupiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Optimus Pharma Molnupiravir Product Portfolio Table 70. Optimus Pharma Recent Development Table 71. Beximco Company Information Table 72. Beximco Business Overview Table 73. Beximco Molnupiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Beximco Molnupiravir Product Portfolio Table 75. Beximco Recent Development Table 76. North America Molnupiravir Revenue by Type (2021-2026) & (US$ Million) Table 77. North America Molnupiravir Revenue by Type (2027-2032) & (US$ Million) Table 78. North America Molnupiravir Sales by Type (2021-2026) & (K Units) Table 79. North America Molnupiravir Sales by Type (2027-2032) & (K Units) Table 80. North America Molnupiravir Sales Price by Type (2021-2026) & (US$/Unit) Table 81. North America Molnupiravir Sales Price by Type (2027-2032) & (US$/Unit) Table 82. North America Molnupiravir Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Molnupiravir Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Molnupiravir Sales by Application (2021-2026) & (K Units) Table 85. North America Molnupiravir Sales by Application (2027-2032) & (K Units) Table 86. North America Molnupiravir Sales Price by Application (2021-2026) & (US$/Unit) Table 87. North America Molnupiravir Sales Price by Application (2027-2032) & (US$/Unit) Table 88. North America Molnupiravir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Molnupiravir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 90. North America Molnupiravir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 91. North America Molnupiravir Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 92. North America Molnupiravir Sales by Country (2021-2026) & (K Units) Table 93. North America Molnupiravir Sales by Country (2027-2032) & (K Units) Table 94. North America Molnupiravir Sales Price by Country (2021-2026) & (US$/Unit) Table 95. North America Molnupiravir Sales Price by Country (2027-2032) & (US$/Unit) Table 96. United States Molnupiravir Revenue (2021-2032) & (US$ Million) Table 97. Canada Molnupiravir Revenue (2021-2032) & (US$ Million) Table 98. Europe Molnupiravir Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Molnupiravir Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Molnupiravir Sales by Type (2021-2026) & (K Units) Table 101. Europe Molnupiravir Sales by Type (2027-2032) & (K Units) Table 102. Europe Molnupiravir Sales Price by Type (2021-2026) & (US$/Unit) Table 103. Europe Molnupiravir Sales Price by Type (2027-2032) & (US$/Unit) Table 104. Europe Molnupiravir Revenue by Application (2021-2026) & (US$ Million) Table 105. Europe Molnupiravir Revenue by Application (2027-2032) & (US$ Million) Table 106. Europe Molnupiravir Sales by Application (2021-2026) & (K Units) Table 107. Europe Molnupiravir Sales by Application (2027-2032) & (K Units) Table 108. Europe Molnupiravir Sales Price by Application (2021-2026) & (US$/Unit) Table 109. Europe Molnupiravir Sales Price by Application (2027-2032) & (US$/Unit) Table 110. Europe Molnupiravir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Molnupiravir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. Europe Molnupiravir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. Europe Molnupiravir Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 114. Europe Molnupiravir Sales by Country (2021-2026) & (K Units) Table 115. Europe Molnupiravir Sales by Country (2027-2032) & (K Units) Table 116. Europe Molnupiravir Sales Price by Country (2021-2026) & (US$/Unit) Table 117. Europe Molnupiravir Sales Price by Country (2027-2032) & (US$/Unit) Table 118. Germany Molnupiravir Revenue (2021-2032) & (US$ Million) Table 119. France Molnupiravir Revenue (2021-2032) & (US$ Million) Table 120. U.K. Molnupiravir Revenue (2021-2032) & (US$ Million) Table 121. Italy Molnupiravir Revenue (2021-2032) & (US$ Million) Table 122. Netherlands Molnupiravir Revenue (2021-2032) & (US$ Million) Table 123. China Molnupiravir Revenue by Type (2021-2026) & (US$ Million) Table 124. China Molnupiravir Revenue by Type (2027-2032) & (US$ Million) Table 125. China Molnupiravir Sales by Type (2021-2026) & (K Units) Table 126. China Molnupiravir Sales by Type (2027-2032) & (K Units) Table 127. China Molnupiravir Sales Price by Type (2021-2026) & (US$/Unit) Table 128. China Molnupiravir Sales Price by Type (2027-2032) & (US$/Unit) Table 129. China Molnupiravir Revenue by Application (2021-2026) & (US$ Million) Table 130. China Molnupiravir Revenue by Application (2027-2032) & (US$ Million) Table 131. China Molnupiravir Sales by Application (2021-2026) & (K Units) Table 132. China Molnupiravir Sales by Application (2027-2032) & (K Units) Table 133. China Molnupiravir Sales Price by Application (2021-2026) & (US$/Unit) Table 134. China Molnupiravir Sales Price by Application (2027-2032) & (US$/Unit) Table 135. Asia Molnupiravir Revenue by Type (2021-2026) & (US$ Million) Table 136. Asia Molnupiravir Revenue by Type (2027-2032) & (US$ Million) Table 137. Asia Molnupiravir Sales by Type (2021-2026) & (K Units) Table 138. Asia Molnupiravir Sales by Type (2027-2032) & (K Units) Table 139. Asia Molnupiravir Sales Price by Type (2021-2026) & (US$/Unit) Table 140. Asia Molnupiravir Sales Price by Type (2027-2032) & (US$/Unit) Table 141. Asia Molnupiravir Revenue by Application (2021-2026) & (US$ Million) Table 142. Asia Molnupiravir Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Molnupiravir Sales by Application (2021-2026) & (K Units) Table 144. Asia Molnupiravir Sales by Application (2027-2032) & (K Units) Table 145. Asia Molnupiravir Sales Price by Application (2021-2026) & (US$/Unit) Table 146. Asia Molnupiravir Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Asia Molnupiravir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Molnupiravir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Asia Molnupiravir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Asia Molnupiravir Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 151. Asia Molnupiravir Sales by Country (2021-2026) & (K Units) Table 152. Asia Molnupiravir Sales by Country (2027-2032) & (K Units) Table 153. Asia Molnupiravir Sales Price by Country (2021-2026) & (US$/Unit) Table 154. Asia Molnupiravir Sales Price by Country (2027-2032) & (US$/Unit) Table 155. Japan Molnupiravir Revenue (2021-2032) & (US$ Million) Table 156. South Korea Molnupiravir Revenue (2021-2032) & (US$ Million) Table 157. India Molnupiravir Revenue (2021-2032) & (US$ Million) Table 158. Australia Molnupiravir Revenue (2021-2032) & (US$ Million) Table 159. China Taiwan Molnupiravir Revenue (2021-2032) & (US$ Million) Table 160. Southeast Asia Molnupiravir Revenue (2021-2032) & (US$ Million) Table 161. SAMEA Molnupiravir Revenue by Type (2021-2026) & (US$ Million) Table 162. SAMEA Molnupiravir Revenue by Type (2027-2032) & (US$ Million) Table 163. SAMEA Molnupiravir Sales by Type (2021-2026) & (K Units) Table 164. SAMEA Molnupiravir Sales by Type (2027-2032) & (K Units) Table 165. SAMEA Molnupiravir Sales Price by Type (2021-2026) & (US$/Unit) Table 166. SAMEA Molnupiravir Sales Price by Type (2027-2032) & (US$/Unit) Table 167. SAMEA Molnupiravir Revenue by Application (2021-2026) & (US$ Million) Table 168. SAMEA Molnupiravir Revenue by Application (2027-2032) & (US$ Million) Table 169. SAMEA Molnupiravir Sales by Application (2021-2026) & (K Units) Table 170. SAMEA Molnupiravir Sales by Application (2027-2032) & (K Units) Table 171. SAMEA Molnupiravir Sales Price by Application (2021-2026) & (US$/Unit) Table 172. SAMEA Molnupiravir Sales Price by Application (2027-2032) & (US$/Unit) Table 173. SAMEA Molnupiravir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. SAMEA Molnupiravir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. SAMEA Molnupiravir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. SAMEA Molnupiravir Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 177. SAMEA Molnupiravir Sales by Country (2021-2026) & (K Units) Table 178. SAMEA Molnupiravir Sales by Country (2027-2032) & (K Units) Table 179. SAMEA Molnupiravir Sales Price by Country (2021-2026) & (US$/Unit) Table 180. SAMEA Molnupiravir Sales Price by Country (2027-2032) & (US$/Unit) Table 181. Brazil Molnupiravir Revenue (2021-2032) & (US$ Million) Table 182. Argentina Molnupiravir Revenue (2021-2032) & (US$ Million) Table 183. Chile Molnupiravir Revenue (2021-2032) & (US$ Million) Table 184. Colombia Molnupiravir Revenue (2021-2032) & (US$ Million) Table 185. Peru Molnupiravir Revenue (2021-2032) & (US$ Million) Table 186. Saudi Arabia Molnupiravir Revenue (2021-2032) & (US$ Million) Table 187. Israel Molnupiravir Revenue (2021-2032) & (US$ Million) Table 188. UAE Molnupiravir Revenue (2021-2032) & (US$ Million) Table 189. Turkey Molnupiravir Revenue (2021-2032) & (US$ Million) Table 190. Iran Molnupiravir Revenue (2021-2032) & (US$ Million) Table 191. Egypt Molnupiravir Revenue (2021-2032) & (US$ Million) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Molnupiravir Distributors List Table 195. Molnupiravir Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Molnupiravir Image Figure 2. Global Molnupiravir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Molnupiravir Market Size Share 2021 VS 2025 VS 2032 Figure 4. Patented Drug Image Figure 5. Generic Drug Image Figure 6. Global Molnupiravir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Molnupiravir Market Size Share 2021 VS 2025 VS 2032 Figure 8. Antiviral Drug Image Figure 9. COVID-19 Image Figure 10. Global Molnupiravir Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Molnupiravir Revenue (2021-2032) & (US$ Million) Figure 12. Global Molnupiravir Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Molnupiravir Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Molnupiravir Revenue Market Share by Region (2021-2032) Figure 15. Global Molnupiravir Sales (2021-2032) & (K Units) Figure 16. Global Molnupiravir Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Molnupiravir Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Molnupiravir Sales YoY (2021-2032) & (K Units) Figure 19. Europe Molnupiravir Sales YoY (2021-2032) & (K Units) Figure 20. China Molnupiravir Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Molnupiravir Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Molnupiravir Sales YoY (2021-2032) & (K Units) Figure 23. Global Molnupiravir Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Molnupiravir Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Molnupiravir Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Molnupiravir Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Molnupiravir Revenue Market Share by Type (2021-2032) Figure 29. Global Molnupiravir Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Molnupiravir Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Molnupiravir Sales Market Share by Type (2021-2032) Figure 32. Global Molnupiravir Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Molnupiravir Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Molnupiravir Revenue Market Share by Application (2021-2032) Figure 35. Global Molnupiravir Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Molnupiravir Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Molnupiravir Sales Market Share by Application (2021-2032) Figure 38. North America Molnupiravir Revenue Share by Type (2021-2032) Figure 39. North America Molnupiravir Sales Share by Type (2021-2032) Figure 40. North America Molnupiravir Revenue Share by Application (2021-2032) Figure 41. North America Molnupiravir Sales Share by Application (2021-2032) Figure 42. North America Molnupiravir Revenue Share by Country (2021-2032) Figure 43. North America Molnupiravir Sales Share by Country (2021-2032) Figure 44. Europe Molnupiravir Revenue Share by Type (2021-2032) Figure 45. Europe Molnupiravir Sales Share by Type (2021-2032) Figure 46. Europe Molnupiravir Revenue Share by Application (2021-2032) Figure 47. Europe Molnupiravir Sales Share by Application (2021-2032) Figure 48. Europe Molnupiravir Revenue Share by Country (2021-2032) Figure 49. Europe Molnupiravir Sales Share by Country (2021-2032) Figure 50. China Molnupiravir Revenue Share by Type (2021-2032) Figure 51. China Molnupiravir Sales Share by Type (2021-2032) Figure 52. China Molnupiravir Revenue Share by Application (2021-2032) Figure 53. China Molnupiravir Sales Share by Application (2021-2032) Figure 54. Asia Molnupiravir Revenue Share by Type (2021-2032) Figure 55. Asia Molnupiravir Sales Share by Type (2021-2032) Figure 56. Asia Molnupiravir Revenue Share by Application (2021-2032) Figure 57. Asia Molnupiravir Sales Share by Application (2021-2032) Figure 58. Asia Molnupiravir Revenue Share by Country (2021-2032) Figure 59. Asia Molnupiravir Sales Share by Country (2021-2032) Figure 60. SAMEA Molnupiravir Revenue Share by Type (2021-2032) Figure 61. SAMEA Molnupiravir Sales Share by Type (2021-2032) Figure 62. SAMEA Molnupiravir Revenue Share by Application (2021-2032) Figure 63. SAMEA Molnupiravir Sales Share by Application (2021-2032) Figure 64. SAMEA Molnupiravir Revenue Share by Country (2021-2032) Figure 65. SAMEA Molnupiravir Sales Share by Country (2021-2032) Figure 66. Molnupiravir Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Molnupiravir Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Patented Drug
  • Generic Drug
Applications
  • Antiviral Drug
  • COVID-19
Companies covered
  • Merck
  • Sun Pharma
  • Optimus Pharma
  • Beximco

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Molnupiravir Market by Type
  3. 1.2.1 Global Molnupiravir Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Patented Drug
  5. 1.2.3 Generic Drug
  6. 1.3 Molnupiravir Market by Application
  7. 1.3.1 Global Molnupiravir Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Antiviral Drug
  9. 1.3.3 COVID-19
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Molnupiravir Market Dynamics
  1. 2.1 Molnupiravir Industry Trends
  2. 2.2 Molnupiravir Industry Drivers
  3. 2.3 Molnupiravir Industry Opportunities and Challenges
  4. 2.4 Molnupiravir Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Molnupiravir Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Molnupiravir Revenue by Region
  3. 3.2.1 Global Molnupiravir Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Molnupiravir Revenue by Region (2021-2026)
  5. 3.2.3 Global Molnupiravir Revenue by Region (2027-2032)
  6. 3.2.4 Global Molnupiravir Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Molnupiravir Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Molnupiravir Sales by Region
  9. 3.4.1 Global Molnupiravir Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Molnupiravir Sales by Region (2021-2026)
  11. 3.4.3 Global Molnupiravir Sales by Region (2027-2032)
  12. 3.4.4 Global Molnupiravir Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Molnupiravir Revenue by Manufacturers
  2. 4.1.1 Global Molnupiravir Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Molnupiravir Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Molnupiravir Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Molnupiravir Sales by Manufacturers
  6. 4.2.1 Global Molnupiravir Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Molnupiravir Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Molnupiravir Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Molnupiravir Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Molnupiravir Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Molnupiravir Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Molnupiravir Manufacturers, Product Type & Application
  13. 4.7 Global Molnupiravir Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Molnupiravir Market CR5 and HHI
  16. 4.8.2 2025 Molnupiravir Tier 1, Tier 2, and Tier 3
5 Molnupiravir Market by Type
  1. 5.1 Global Molnupiravir Revenue by Type
  2. 5.1.1 Global Molnupiravir Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Molnupiravir Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Molnupiravir Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Molnupiravir Sales by Type
  6. 5.2.1 Global Molnupiravir Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Molnupiravir Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Molnupiravir Sales Market Share by Type (2021-2032)
  9. 5.3 Global Molnupiravir Price by Type
6 Molnupiravir Market by Application
  1. 6.1 Global Molnupiravir Revenue by Application
  2. 6.1.1 Global Molnupiravir Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Molnupiravir Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Molnupiravir Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Molnupiravir Sales by Application
  6. 6.2.1 Global Molnupiravir Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Molnupiravir Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Molnupiravir Sales Market Share by Application (2021-2032)
  9. 6.3 Global Molnupiravir Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Molnupiravir Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Molnupiravir Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Sun Pharma
  8. 7.2.1 Sun Pharma Company Information
  9. 7.2.2 Sun Pharma Business Overview
  10. 7.2.3 Sun Pharma Molnupiravir Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sun Pharma Molnupiravir Product Portfolio
  12. 7.2.5 Sun Pharma Recent Developments
  13. 7.3 Optimus Pharma
  14. 7.3.1 Optimus Pharma Company Information
  15. 7.3.2 Optimus Pharma Business Overview
  16. 7.3.3 Optimus Pharma Molnupiravir Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Optimus Pharma Molnupiravir Product Portfolio
  18. 7.3.5 Optimus Pharma Recent Developments
  19. 7.4 Beximco
  20. 7.4.1 Beximco Company Information
  21. 7.4.2 Beximco Business Overview
  22. 7.4.3 Beximco Molnupiravir Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Beximco Molnupiravir Product Portfolio
  24. 7.4.5 Beximco Recent Developments
8 North America
  1. 8.1 North America Molnupiravir Market Size by Type
  2. 8.1.1 North America Molnupiravir Revenue by Type (2021-2032)
  3. 8.1.2 North America Molnupiravir Sales by Type (2021-2032)
  4. 8.1.3 North America Molnupiravir Price by Type (2021-2032)
  5. 8.2 North America Molnupiravir Market Size by Application
  6. 8.2.1 North America Molnupiravir Revenue by Application (2021-2032)
  7. 8.2.2 North America Molnupiravir Sales by Application (2021-2032)
  8. 8.2.3 North America Molnupiravir Price by Application (2021-2032)
  9. 8.3 North America Molnupiravir Market Size by Country
  10. 8.3.1 North America Molnupiravir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Molnupiravir Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Molnupiravir Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Molnupiravir Market Size by Type
  2. 9.1.1 Europe Molnupiravir Revenue by Type (2021-2032)
  3. 9.1.2 Europe Molnupiravir Sales by Type (2021-2032)
  4. 9.1.3 Europe Molnupiravir Price by Type (2021-2032)
  5. 9.2 Europe Molnupiravir Market Size by Application
  6. 9.2.1 Europe Molnupiravir Revenue by Application (2021-2032)
  7. 9.2.2 Europe Molnupiravir Sales by Application (2021-2032)
  8. 9.2.3 Europe Molnupiravir Price by Application (2021-2032)
  9. 9.3 Europe Molnupiravir Market Size by Country
  10. 9.3.1 Europe Molnupiravir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Molnupiravir Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Molnupiravir Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Molnupiravir Market Size by Type
  2. 10.1.1 China Molnupiravir Revenue by Type (2021-2032)
  3. 10.1.2 China Molnupiravir Sales by Type (2021-2032)
  4. 10.1.3 China Molnupiravir Price by Type (2021-2032)
  5. 10.2 China Molnupiravir Market Size by Application
  6. 10.2.1 China Molnupiravir Revenue by Application (2021-2032)
  7. 10.2.2 China Molnupiravir Sales by Application (2021-2032)
  8. 10.2.3 China Molnupiravir Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Molnupiravir Market Size by Type
  2. 11.1.1 Asia Molnupiravir Revenue by Type (2021-2032)
  3. 11.1.2 Asia Molnupiravir Sales by Type (2021-2032)
  4. 11.1.3 Asia Molnupiravir Price by Type (2021-2032)
  5. 11.2 Asia Molnupiravir Market Size by Application
  6. 11.2.1 Asia Molnupiravir Revenue by Application (2021-2032)
  7. 11.2.2 Asia Molnupiravir Sales by Application (2021-2032)
  8. 11.2.3 Asia Molnupiravir Price by Application (2021-2032)
  9. 11.3 Asia Molnupiravir Market Size by Country
  10. 11.3.1 Asia Molnupiravir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Molnupiravir Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Molnupiravir Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Molnupiravir Market Size by Type
  2. 12.1.1 SAMEA Molnupiravir Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Molnupiravir Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Molnupiravir Price by Type (2021-2032)
  5. 12.2 SAMEA Molnupiravir Market Size by Application
  6. 12.2.1 SAMEA Molnupiravir Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Molnupiravir Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Molnupiravir Price by Application (2021-2032)
  9. 12.3 SAMEA Molnupiravir Market Size by Country
  10. 12.3.1 SAMEA Molnupiravir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Molnupiravir Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Molnupiravir Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Molnupiravir Value Chain Analysis
  2. 13.1.1 Molnupiravir Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Molnupiravir Production Mode & Process
  6. 13.2 Molnupiravir Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Molnupiravir Distributors
  9. 13.2.3 Molnupiravir Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst